Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. van Moorsel, J. van der Vis, M. van Oosterhout, H. Ruven, P. de Jong, W. van Es, J. van den Bosch, J. Grutters (Nieuwegein, Utrecht, Netherlands). Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes. Eur Respir J 2011; 38: Suppl. 55, 1994

Member's Comments

No comment yet.

Related content which might interest you: Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis Source: Eur Respir J 2015; 46: 474-485 Year: 2015 Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations. Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 First heterozygous NOP10 mutation in familial pulmonary fibrosis Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019 Year: 2020 Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis Source: Eur Respir J 2016; 48: 1721-1731 Year: 2016 Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations Source: Eur Respir J 2014; 43: 638-641 Year: 2013 Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles Source: Eur Respir J 2004; 24 : 798-804 Year: 2004 Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Progressive lung disease caused by ABCA3 mutation Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Intersitial lung disease in chlidren with mutation in the  SFTPC and SFPTB gene: A two case report Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017 Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020 Year: 2020 The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required? Source: Eur Respir J 2014; 44: 270-271 Year: 2014 Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required? Source: Eur Respir J 2014; 44: 269-270 Year: 2014 Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes Source: Eur Respir J, 53 (2) 1800508; 10.1183/13993003.00508-2018 Year: 2019 Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 148s Year: 2006 Pulmonary fibrosis linked to variants in the ACD gene, encoding the telomere protein TPP1 Source: Eur Respir J, 54 (6) 1900809; 10.1183/13993003.00809-2019 Year: 2019 MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016